Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» asciminib
asciminib
Novartis’ Scemblix meets primary endpoints in Phase III leukemia trial
Clinical Trials Arena
Mon, 01/8/24 - 11:41 am
Novartis
clinical trials
Scemblix
asciminib
CML
ASH20: Out to shake up CML once again, Novartis lays out head-to-head between third-gen Gleevec scion and Pfizer rival
Endpoints
Tue, 12/8/20 - 11:08 pm
ASH2020
Novartis
CML
asciminib
Pfizer
Novartis’ ABL001 meets primary endpoint of phase 3 chronic myeloid leukemia study
Pharmaceutical Business Review
Thu, 08/27/20 - 11:01 am
Novartis
asciminib
ABL001
clinical trials
chronic myeloid leukemia